Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$0.35 - $0.74 $19,425 - $41,070
-55,500 Reduced 34.47%
105,500 $40,000
Q1 2023

May 15, 2023

BUY
$0.72 - $1.21 $26,280 - $44,165
36,500 Added 29.32%
161,000 $123,000
Q4 2022

Feb 14, 2023

SELL
$0.82 - $1.36 $83,148 - $137,904
-101,400 Reduced 44.89%
124,500 $114,000
Q3 2022

Nov 14, 2022

BUY
$0.91 - $2.27 $97,006 - $241,982
106,600 Added 89.35%
225,900 $209,000

Others Institutions Holding XXII

About 22nd Century Group, Inc.


  • Ticker XXII
  • Exchange NASDAQ
  • Sector Consumer Defensive
  • Industry Tobacco
  • Shares Outstandng 214,784,992
  • Market Cap $23.6M
  • Description
  • 22nd Century Group, Inc., an agricultural biotechnology company, focuses on tobacco harm reduction, reduced nicotine tobacco, and enhancing health and wellness through plant science for the life science and consumer products industries. It develops very low nicotine content tobacco and cigarette products under the VLN King and VLN Menthol King n...
More about XXII
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.